Missed opportunities in discussing LARC
We conducted a study on the feasibility of selfcompleted history questionnaires in a central London community contraceptive clinic in October 2006. Participants were established users of combined hormonal contraception (CHC, which includes the pill and the patch) requesting repeat supplies. 1 Along with questions on personal and family history to identify risk factors, we included a question: "Would you like to discuss other methods of contraception such as long-acting methods which you do not have to remember to take each day?" Twenty-one percent (68/328) of women replied 'Yes' to this question. This is an important finding, considering the fact that these women were already well established on their CHC.
Given this response, we suggest that when a woman comes for repeat supplies of her CHC, it should be taken as an opportunity to discuss longacting reversible contraception (LARC) methods. Choice of contraception is essential to meet diverse user needs, and preferences may change with the user's stage in life. Only by offering choice will the maximum number of women be protected and will the uptake of LARC increase. If health professionals make assumptions that a woman's current method of contraception is the best and most acceptable to her, they could be missing opportunities for discussing other methods.
National Institute for Health and Clinical Excellence (NICE) guidance recommends that all women requiring contraception should be given information about, and offered a choice of, all methods, including LARC. 2 Little is known about the extent to which women requesting contraception are actually offered these methods. In general practice the availability of LARC methods is often limited, which is also likely to affect uptake. 3 LARC offers definite cost benefits to health services, with all methods being more costeffective than the combined oral contraceptive pill even at 1 year of use. 2 In addition, these methods offer non-contraceptive health benefits, such as the levonorgestrel intrauterine system providing treatment for menorrhagia. 2 Non-use of contraception places a far heavier financial burden on society and public funds. 4 In the UK, an estimated 50% of pregnancies are unplanned and approximately one-fifth of conceptions end in legal abortions. 3 An increased uptake of LARC could help to reduce unintended pregnancy.
We support the view that improving access to the full range of contraceptive methods and increasing nationally accredited training for all contraception providers is required. 3 The potential benefits of LARC methods over CHC can actually be realised if this is applied as an auditable standard for all clinicians involved in contraceptive care.
